Overview

Nerve Repair and Re-generation Market is forecasted to value over CAGR of 14% from the forecast period 2022-2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Nerve Repair and Re-generation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market.
According to the research study conducted by FutureWise research analysts, the Nerve Repair and Re-generation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Nerve Repair and Re-generation Market along with the growth opportunities present across this business vertical.

Major players included in the Nerve Repair and Re-generation Market are:    

• Stryker    
• Axogen  
• Integra    
• Polyganics  
• Baxter
• Boston Scientific
• Livanova
• Medtronic
• Abbott Laboratories
• Nuvectra
• Neuropace
• Orthomed
• Nevro

(Note: The list of the major players will be updated with the latest market scenario and trends)

Nerve Repair and Re-generation Market Segmentation:

By Product

• Neurostimulation and Neuromodulation Devices
  o Internal Neurostimulation Devices
    o Spinal Cord Stimulation
    o Deep Brain Stimulation
    o Vagus Nerve Stimulation
    o Sacral Nerve Stimulation
    o Gastric Electrical Stimulation
  o External Neurostimulation Devices
    o Transcutaneous Electrical Nerve Stimulation
    o Transcranial Magnetic Stimulation
• Biomaterials
  o Nerve Conduits
  o Nerve Protectors
  o Nerve Wraps
  o Nerve Connectors

By Application

• Neurostimulation and Neuromodulation Surgeries
  o Internal Neurostimulation and Neuromodulation Surgeries
  o External Neurostimulation and Neuromodulation Surgeries
• Direct Nerve Repair/Neurorrhaphy
  o Epineural Repair
  o Perineural Repair
  o Group Fascicular Repair
• Nerve Grafting
  o Autografts
  o Allografts
  o Xenografts
• Stem Cell Therapy

By End User

• Hospitals & Clinics
• Ambulatory Surgery Centers

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Nerve Repair and Re-generation Market by product, by application, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advan Terumoents, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1 Objectives of the Study 
        1.2 Market Definition 
        1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered                  
        1.4 Currency   
        1.5 Limitations 
        1.6 Stakeholders 
2. Research Methodology 
        2.1 Research Data 
            2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
            2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
        2.2 Market Size Estimation 
        2.3 Market Breakdown and Data Triangulation 
        2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Nerve Repair and Re-generation Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Nerve Repair and Re-generation Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Nerve Repair and Re-generation Market, By product Historical Analysis and Forecast 2022-2028 (USD Million)

         7.1. Neurostimulation and Neuromodulation Devices

                7.1.1. Internal Neurostimulation Devices

                            7.1.1.1. Spinal Cord Stimulation

                            7.1.1.2. Deep Brain Stimulation

                            7.1.1.3. Vagus Nerve Stimulation

                            7.1.1.4. Sacral Nerve Stimulation

                            7.1.1.5. Gastric Electrical Stimulation

                7.1.2. External Neurostimulation Devices

                            7.1.2.1. Transcutaneous Electrical Nerve Stimulation

                            7.1.2.2. Transcranial Magnetic Stimulation

         7.2. Biomaterials

                7.2.1. Nerve Conduits

                7.2.2. Nerve Protectors

                7.2.3. Nerve Wraps

                7.2.4. Nerve Connectors

8. Global Nerve Repair and Re-generation Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)

         8.1. Neurostimulation and Neuromodulation Surgeries

                8.1.1. Internal Neurostimulation and Neuromodulation Surgeries

                8.1.2. External Neurostimulation and Neuromodulation Surgeries

         8.2. Direct Nerve Repair/Neurorrhaphy

                8.2.1. Epineural Repair

                8.2.2. Perineural Repair

                8.2.3. Group Fascicular Repair

         8.3. Nerve Grafting

                8.3.1. Autografts

                8.3.2. Allografts

                8.3.3. Xenografts

         8.4. Stem Cell Therapy

9. Global Nerve Repair and Re-generation Market, By end-user Historical Analysis and Forecast 2022-2028 (USD Million)

         9.1.Hospitals & Clinics

         9.2.Ambulatory Surgery Centers

10.  North America Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) along with expected regulatory needs
     10.1. Introduction
     10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.2.1. U.S.A
            10.2.2. Canada
            10.2.3. Mexico
     10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Europe Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
     11.1. Introduction
     11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           11.2.1. Germany
           11.2.2. U.K
           11.2.3. France
           11.2.4. Italy
           11.2.5. Spain
           11.2.6. Russia
           11.2.7. Poland
           11.2.8. Switzerland
           11.2.9. Rest of Western Europe
12. Asia Pacific Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) - along with expected regulatory needs
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 
             12.2.1. Japan
             12.2.2. China
             12.2.3. Singapore
             12.2.4. India
             12.2.5. Australia and New Zealand
             12.2.6. ASEAN
             12.2.7. South Korea
             12.2.8. Rest of Asia Pacific
        12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028

13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)

         13.1. Introduction

         13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                   13.2.1. GCC
                   13.2.2. Israel
                   13.2.3. South Africa
                   13.2.4. Rest of MEA

         13.3. Market Size (USD Million) Forecast for MEA 2022-2028

14. Rest of the World Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) along with expected regulatory needs
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             14.2.1. Saudi Arabia
             14.2.2. UAE
             14.2.3. South Africa
             14.2.4. Egypt
        14.3. Market Size (USD Million) Forecast for MEA 2022-2028          
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

         15.1. Stryker

                15.1.1. Company Overview

                15.1.2. Product Portfolio

                15.1.3. SWOT Analysis

                15.1.4. Financial Overview

                15.1.5. Strategic Overview

         15.2. AXOGEN  

                15.2.1. Company Overview

                15.2.2. Product Portfolio

                15.2.3. SWOT Analysis

                15.2.4. Financial Overview

                15.2.5. Strategic Overview

         15.3. INTEGRA    

                15.3.1. Company Overview

                15.3.2. Product Portfolio

                15.3.3. SWOT Analysis

                15.3.4. Financial Overview

                15.3.5. Strategic Overview

         15.4. Polyganics  

                15.4.1. Company Overview

                15.4.2. Product Portfolio

                15.4.3. SWOT Analysis

                15.4.4. Financial Overview

                15.4.5. Strategic Overview

         15.5. Baxter

                15.5.1. Company Overview

                15.5.2. Product Portfolio

                15.5.3. SWOT Analysis

                15.5.4. Financial Overview

                15.5.5. Strategic Overview

         15.6. Boston Scientific

                15.6.1. Company Overview

                15.6.2. Product Portfolio

                15.6.3. SWOT Analysis

                15.6.4. Financial Overview

                15.6.5. Strategic Overview

         15.7. Livanova 

                15.7.1. Company Overview

                15.7.2. Product Portfolio

                15.7.3. SWOT Analysis

                15.7.4. Financial Overview

                15.7.5. Strategic Overview

         15.8. Medtronic

                15.8.1. Company Overview

                15.8.2. Product Portfolio

                15.8.3. SWOT Analysis

                15.8.4. Financial Overview

                15.8.5. Strategic Overview

         15.9. Abbott Laboratories

                15.9.1. Company Overview

                15.9.2. Product Portfolio

                15.9.3. SWOT Analysis

                15.9.4. Financial Overview

                15.9.5. Strategic Overview

         15.10. Nuvectra

                15.10.1. Company Overview

                15.10.2. Product Portfolio

                15.10.3. SWOT Analysis

                15.10.4. Financial Overview

                15.10.5. Strategic Overview

         15.11. Neuropace 

                15.11.1. Company Overview

                15.11.2. Product Portfolio

                15.11.3. SWOT Analysis

                15.11.4. Financial Overview

                15.11.5. Strategic Overview

         15.12. Orthomed

                15.12.1. Company Overview

                15.12.2. Product Portfolio

                15.12.3. SWOT Analysis

                15.12.4. Financial Overview

                15.12.5. Strategic Overview

         15.13. Nevro

                15.13.1. Company Overview

                15.13.2. Product Portfolio

                15.13.3. SWOT Analysis

                15.13.4. Financial Overview

                15.13.5. Strategic Overview
16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. FutureWise SME key takeaway points for Client

Tables

Figures